Abstract

Proliferative and aberrant cellular activities of human tissues were evaluated using a novel double staining technique for histone H3 (with in situ hybridization) and immunohistochemistry for p53 protein. Simultaneous analyses were run on tissue sections of papillomas, squamous cell carcinomas (SCC) and normal non-neoplastic stratified squamous epithelia from human oral specimens using formalin-fixed, paraffin-embedded material. Sections were first FITC-labeled histone H3 DNA probe and then treated with alkaline phosphatase-conjugated anti-FITC rabbit antibody. Following reaction with anti-p53 protein mouse monoclonal antibody using the labeled streptavidin-biotin (LSAB) method, sections were stained with 3-amino-9-ethylcarbazole-HCI to detect p53 protein, and with 5-bromo-4-chloro-3-indoxy phosphate/nitro blue tetrazolium to detect histone H3 mRNA. Several methods differing only in the order of detection procedures were employed and subsequently compared. Using these methods, histone H3 mRNA and p53 protein were detected both within the cytoplasm and the nucleus, respectively. Histone H3 mRNA and p53 protein were expressed in larger cell populations in the following order: SCC, papilloma, and nonneoplastic stratified squamous epithelia. The double staining as employed here proved effective for simultaneous evaluation of cell proliferative activity as well as the overexpression of aberrant gene on the same tissue sections.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.